Skip to product information
1 of 1

Mouse Anti-Human CD140b Antibody (S-3078)

Mouse Anti-Human CD140b Antibody (S-3078)

Catalog Number: S0B80126 Application: FCM Reactivity: Hu Conjugation: Unconjugated Brand: Starter
Price:
Regular price $45 USD
Regular price Sale price $45 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen CD140b
Synonyms Platelet-derived growth factor receptor beta; PDGF-R-beta; PDGFR-beta; Beta platelet-derived growth factor receptor; Beta-type platelet-derived growth factor receptor; CD140 antigen-like family member B; Platelet-derived growth factor receptor 1 (PDGFR-1); PDGFR; PDGFR1; PDGFRB
Location Cell membrane
Accession P09619
Clone Number S-3078
Antibody Type Mouse mAb
Isotype IgG2a,k
Application FCM
Reactivity Hu
Positive Sample CD104b transfected 293F
Purification Protein A
Concentration 2 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS pH7.4

Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Dilution


application dilution species
FCM 1:200 Hu

Background

CD140b, also known as Platelet-Derived Growth Factor Receptor Beta (PDGFR-β), is a transmembrane receptor tyrosine kinase encoded by the PDGFRB gene in humans, playing a pivotal role in regulating cell proliferation, migration, survival, and differentiation, particularly within mesenchymal lineages such as vascular smooth muscle cells, pericytes, and fibroblasts. Structurally, it consists of an extracellular ligand-binding domain, a single transmembrane helix, and an intracellular tyrosine kinase domain that becomes activated upon binding to specific dimeric isoforms of platelet-derived growth factor (primarily PDGF-BB and PDGF-DD), triggering autophosphorylation and the subsequent recruitment of downstream signaling molecules involved pathways like PI3K/AKT, RAS/MAPK, and PLCγ. This receptor is essential for normal embryonic development, especially in the formation of the cardiovascular system and kidney, while its dysregulation or overexpression is strongly implicated in various pathological conditions, including atherosclerosis, pulmonary hypertension, fibrotic diseases, and certain malignancies such as gliomas and chronic myelomonocytic leukemia, making it a significant therapeutic target for tyrosine kinase inhibitors like imatinib.

Picture

FC

Flow cytometric analysis of 293F (Human embryonic kidney epithelial cell, left) / CD140b transfected 293F (right) labelled with CD140b antibody at 1/200 dilution (1 μg) / (red) compared with a Mouse IgG2a, κ(black) Isotype Control. Goat Anti - Mouse IgG Alexa Fluor® 488 was used as the secondary antibody. Flow cytometry and data analysis were performed using Agilent NovoCyte Quanteon and FlowJo™ software.
Negative control: 293F